© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
October 06, 2017
Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.
October 05, 2017
A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.
Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.
Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.
Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.
The investigational regimen may be appropriate for a broad range of HIV-positive patients.